Relationship Between Sclerostin and Left Ventricular Hypertrophy in Patients with Pre-dialysis Chronic Kidney Disease
摘要
The Dickkopf wingless (Wnt/β-katenin) signalling pathway is a significant signalling network for cardiovascular diseases.
ObjectiveThe aim of our study was to investigate the relationship between sclerostin and left ventricular (LV) mass index (LVMI), as well as LVH, in predialysis CKD patients.
MethodsThe study included 282 stage 3–5 predialysis CKD patients. Renal functions were determined by spot urine protein/creatinine ratio (SUPC) and estimated glomerular filtration rate (eGFR). Echocardiography was used to calculate LV ejection fraction (LVEF), left atrium diameter (LAD), LV end-diastolic diameter (LVEDD), and LV end-systolic diameter (LVESD.
ResultsIn the patients, increased SUPC, sclerostin, LAD, LVMI, LVH, and decreased eGFR and LVEF were observed compared to healthy individuals. In correlation analysis, a significant positive correlation was found between log10 sclerostin and LVMI, as well as LVH, while an inverse relationship was observed with eGFR.
ConclusionIncreased sclerostin levels and development of LVH were observed in stage 3–5 pre-dialysis CKD patients compared to healthy individuals. An inverse relationship was found between sclerostin and eGFR, and significant relationships were observed with LVMI and LVH. Elevated sclerostin levels in pre-dialysis CKD patients may induce cardiac myocyte hypertrophy through an unknown receptor or mechanism.